Solventum Corp reported $14.24B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Align Technology USD 6.42B 103.41M Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Cencora USD 81.65B 3.29B Mar/2026
Dexcom USD 6.46B 178M Jun/2026
Insulet USD 3.17B 177.9M Jun/2026
Solventum Corp USD 14.24B 146M Jun/2026
West Pharmaceutical Services USD 4.08B 33.4M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026